KHURSHID HAQUE: Open Payments
NPI 1700554607 · ALLENTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$640 in 26 payments from 8 companies in 2025. Trend: 2023 $238 · 2024 $55 · 2025 $640
Food & beverage: $640
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $277 |
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| Madrigal Pharmaceuticals | 1 | $79 |
| ABBVIE INC. | 4 | $70 |
| Lundbeck LLC | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: REXULTI, COBENFY, REZDIFFRA, VRAYLAR, INVEGA SUSTENNA, FANAPT, UZEDY.
Industry payments across PA — which companies pay providers there.
